The Effect of Several Commonly Used Antipsychotic Drugs on the Renal Function of Patients with Mental Illness
- 1 Inspection Department of the Second People’s Hospital of Mengshan County, Mengshan, China
- 2 Inspection Department of Chongzuo Maternal and Child Health Care Hospital, Chongzuo, China
- 3 Inspection Department of Nanning Third People’s Hospital, Nanning, China
- 4 The Second Department of Guigang Orthopaedic Hospital of Integrated Traditional Chinese and Western Medicine, Guigang, China
Abstract
Objective: To understand the effects of several commonly used antipsychotics on the renal function of patients with mental illness. Method: Collected patients with mental illness who were hospitalized in our hospital from January 2020 to June 2021, and selected as the research subjects patients with psychiatric disorders who were treated with 2 kinds of commonly used antipsychotic drugs; and collected 3 ml of venous blood before treatment and one month after treatment for renal function tests; observed the changes of renal function indexes before and after treatment. Results: In the collected 694 patients with mental illness, before using antipsychotic drugs, the renal function indexes were BUN: 4.42 ± 1.92 mmol/l; Cr: 70.97 ± 16.92 μmol/l; CCr: 88.37 ± 21.07 ml/min; β2-MG: 1.67 ± 0.61 mg/L; UA: 359.90 ± 112.82 μmol/l; CYS-C: 0.92 ± 0.24 mg/L. One month after using antipsychotics, BUN: 3.77 ± 1.37 mmol/l; Cr: 70.46 ± 16.71 μmol/l; CCr: 87.78 ± 20.63 ml/min; β2-MG: 1.75 ± 0.64 mg/L; UA: 332.53 ± 91.48 umol/l; CYS-C: 0.92 ± 0.24 mg/L; the renal function indexes of urea nitrogen, β2 microglobulin, uric acid and other items all changed significantly. The differences before and after treatment were statistically significant, P < 0.01. Conclusion: Several commonly used antipsychotic drugs have a greater impact on the renal function of patients with mental illness. During the treatment, the changes in renal function should be monitored regularly, if severe renal damage is found, the treatment plan or dosage should be adjusted in time to avoid endangering life.
- Xu, J.J., Hou, X.M., Bi, Z.K., et al. (2016) Comparative Study of the Effects of Clozapine, Chlorpromazine, and Risperidone on the Renal Function of Patients with Schizophrenia. Chinese Journal of Clinicians, 44, 67-68.
- Zhou, Y., Fu, Q.W., Wu, C.D., et al. (2018) Effects of Low-Dose Metformin on Bone Metabolism, Insulin and Renal Function in Patients with Schizophrenia Caused by Oral Clozapine with Abnormal Glucose Metabolism. Hebei Medicine, 24, 111-115.
- Wang, G.Q. and Yi, X.R. (2017) Changes in Related Metabolic Indexes and Liver and Kidney Function during the Treatment of Schizophrenia with Risperidone. Laboratory Medicine and Clinics, 14, 1085-1086.
- Yuan, D.R., Zhang, X.R., Lu, R., et al. (2015) The Effect of Blood Lipid Levels on the Plasma Concentration of Olanzapine in Patients with Schizophrenia. Sichuan Mental Health, No. 4, 310-313.
- Song, J.D. and Wang, W. (2017) The Effect of Astragalus Adjuvant Treatment of Chronic Schizophrenia with Metabolic Syndrome on the Antioxidant Capacity and Liver and Kidney Functions of Patients. Chinese Journal of Biochemical Pharmaceutics, No. 7, 157-158.
- Sun, W.W., Cheng, Y.Q., Chen, X.Y., et al. (2017) Study on the Blood Concentration and Clinical Efficacy of Paliperidone in the Treatment of Schizophrenia. China Journal of Modern Medicine, 27, 126-130.
- Ruan, S.F. and Bu, L.H. (2018) Clinical Pharmacist’s Pharmaceutical Care for Patients with Schizophrenia and Diabetes Mellitus. Evaluation and Analysis of Medication in Chinese Hospitals, 18, 1140-1142.
- Han, Y.C., Jia, J.M., Huang, T.X., et al. (2016) The Effect of Metformin on Glucose and Lipid Metabolism in Patients with Schizophrenia Complicated with Metabolic Syndrome and Its Safety Analysis. Journal of Psychiatry, 29, 443-447.
- Liu, S.H. (2015) Analysis of the Efficacy of Amisulpride and Risperidone in the Treatment of Negative Symptoms of Schizophrenia. Jiangxi Medicine, 50, 1227-1229.
- Zhang, M.Y. (2018) Schizophrenia Requires Long-Term Treatment. Chinese Journal of Psychiatry, 51, 65-66.
- Zhang, Q., Liu, Q., Zhou, J., et al. (2017) Comparative Study of the Effects of Clozapine, Chlorpromazine and Risperidone on the Renal Function of Patients with Schizophrenia. World Clinical Drugs, 38, 822-825.
- Zou, Y.Z. and Kong, Y.Y. (2019) Application and Safety Analysis of Combined Use of Antipsychotic Drugs in the Treatment of Patients with Schizophrenia. China Journal of Modern Medicine, 21, 101-103.